Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study.
Nat Cancer
; 3(5): 552-564, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35332334
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Type of study:
Observational_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Nat Cancer
Year:
2022
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Reino Unido